AKT1 and cancer: Panpan Zhang et al. proved when phosphatidylinositol 3-kinase/protein kinase B signaling was inhibited by corresponding inhibitors, PD-L1 expression was downregulated, and apoptosis was upregulated in the cisplatin-treated cancer cells.